Coronary Artery Disease

Clinical Trial Finder

Many patients with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

STable Coronary Artery Diseases RegisTry

Condition:   Chronic Ischemic Heart Disease
Intervention:   Other: Data collection on Stable Ischemic heart disease
Sponsor:   Heart Care Foundation
Completed

The Evaluation of Fractional Flow Reserve and D SPECT for the Intervention of Chronic Total Occlusion

Condition:   Coronary Artery Disease
Intervention:   Other: fractional flow reserve and SPECT detection
Sponsor:   Shanghai Zhongshan Hospital
Not yet recruiting

Multidisciplinary Program Based in High Intensity Interval Training and Dietary Education for Coronary Artery Disease

Condition:   Coronary Artery Disease
Interventions:   Other: Dietary and physiotherapy;   Other: Physiotherapy
Sponsor:   University of Valencia
Completed

Improved Prediction of Functional Recovery After Revascularisation Using Combined Assessment of Myocardial Ischaemia and Viability by CMR - Pilot Study

Conditions:   Cardiovascular Diseases;   Ischemic Cardiomyopathy;   Cardiac Ischemia
Interventions:   Device: Research CMR scan;   Device: Research 3D transthoracic echocardiogram;   Other: 6-minute walk test
Sponsor:   King's College London
Recruiting

Multi-omics Study of Clinical Endpoints in CHD

Condition:   Coronary Heart Disease
Interventions:   Other: risk factors of adverse cardiovascular events;   Other: multi-omics target discovery;   Other: validation;   Other: Predictive mathematical models
Sponsors:   Guangdong General Hospital;   RenJi Hospital;   West China Hospital;   Xiangya Hospital of Central South University;   First Affiliated Hospital, Sun Yat-Sen University
Recruiting

Rota China Registry

Condition:   Coronary Artery Disease With Myocardial Infarction
Intervention:   Procedure: Rotational Atherectomy
Sponsors:   Beijing Anzhen Hospital;   Boston Scientific International Medical Trading (Shanghai) Co., Ltd.
Recruiting

PeRcutaneous cOronary Intervention of Native Coronary arTery Versus Venous Bypass Graft in Patients With Prior CABG

Condition:   Coronary Artery Disease
Intervention:   Procedure: Percutaneous coronary intervention
Sponsor:   VU University Medical Center
Not yet recruiting

Association Between IVUS Parameters and Invasive Physiologic Indices

Condition:   Ischemic Heart Disease
Intervention:   Diagnostic Test: IVUS and Invasive physiologic indices
Sponsors:   Seoul National University Hospital;   Samsung Medical Center
Recruiting

Multicenter Registry for Angiography-Derived Quantitative Flow Ratio

Condition:   Ischemic Heart Disease
Intervention:   Diagnostic Test: QFR assessment
Sponsors:   Samsung Medical Center;   Seoul National University Hospital;   Inje Univeristy Ilsan Paik Hospital;   Dongsan Medical Center;   Chosun University Hospital;   SaeHan NK & D
Recruiting

One-Dimensional Mathematical Model-Based Automated Assessment of Fractional Flow Reserve

Condition:   Coronary Artery Disease
Intervention:   Device: FFR
Sponsor:   I.M. Sechenov First Moscow State Medical University
Recruiting

Ticagrelor Monotherapy in PAtients Treated With New-generation Drug-eluting Stents for Acute Coronary Syndrome; T-PASS Trial

Condition:   Coronary Artery Disease, Acute Coronary Syndrome
Interventions:   Drug: Standard DAPT;   Drug: Very-short DAPT less than 1 month after PCI
Sponsor:   Yonsei University
Not yet recruiting

Repeatability and Reproducibility of the CADence™System

Condition:   Coronary Artery Disease
Intervention:   Device: CADence testing will be performed
Sponsor:   AUM Cardiovascular, Inc.
Not yet recruiting

The Evaluation of the Roles of New Cardiac Imaging in Patients With Chest Pain

Conditions:   Cardiology;   Radiology;   Stenoses
Intervention:   Device: CT-FFR and CTP
Sponsor:   Lancaster General Hospital
Not yet recruiting

Dyslipidemia Prevalence, Perception, Treatment, and Awareness in the Tunisian Population

Conditions:   Dyslipidemias;   Atherosclerosis;   Households;   Survey, Family Life
Intervention:  
Sponsors:   Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose;   Biochimie Clinique LR99ES11;   Department of Biochemistry, La Rabta Hospital, Tunisia.;   Ministry of Health, Tunisia;   Ministry of Interior, Tunisia;   Direction des Soins de Santé de Base;   National Institute of Statistics;   National Institute of Public Health of Tunisia;   Dacima Consulting
Recruiting

Development and Usability Testing of HEARTPA♀N

Conditions:   Pain;   Cardiac Ischemia;   Women;   Pain, Chronic
Intervention:   Behavioral: HEARTPA♀N
Sponsor:   University of Toronto
Not yet recruiting

A Randomized, Two-arm, Open Label Study to evalUate the Effect of a Smart Phone-based Patient Support Tool On Patient AdheRence of Treatment in Stable Angina Patients Prescribed Beta-blockers in China (SUPPORT)

Conditions:   Adrenergic Beta-Antagonists;   Stable Angina Pectoris;   Medication Adherence;   Mobile Applications
Intervention:   Device: Patient support tool
Sponsor:   Shenyang Northern Hospital
Not yet recruiting

A Nurse Cohort Study in Xiamen, China

Condition:   Hypertension
Intervention:   Other: No intervention
Sponsor:   The First Affiliated Hospital of Xiamen University
Not yet recruiting

Impact of OSA on Outcomes in Acute Coronary Syndrome

Conditions:   OSA;   ACS - Acute Coronary Syndrome;   Major Adverse Cardiac Events
Intervention:   Diagnostic Test: ApneaLink Type III portable sleep study
Sponsor:   MetroHealth Medical Center
Recruiting

A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal

Condition:   Diabetes Mellitus, Type 2
Intervention:   Other: No treatment given
Sponsor:   Novo Nordisk A/S
Not yet recruiting

EVOlocumab in Stable Heart Failure With Reduced Ejection Fraction of Ischemic Etiology: EVO-HF Pilot

Condition:   Heart Failure With Reduced Ejection Fraction (HFrEF) of Ischemic Etiology
Intervention:   Drug: Evolocumab
Sponsor:   Fundació Institut Germans Trias i Pujol
Recruiting

Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients

Condition:   Upper Gastrointestinal Bleeding
Interventions:   Other: restart NOAC very early;   Other: restart NOAC early
Sponsor:   Chinese University of Hong Kong
Not yet recruiting

Providing Patient Information and CT Examination Results

Conditions:   Chest Pain;   Nonmalignant Condition
Intervention:   Other: Extended information
Sponsor:   Haukeland University Hospital
Recruiting

Influence of Extracorporeal Circulation on the Development of OSA (Obstructive Sleep Apnea)

Condition:   Coronary Artery Disease
Intervention:   Diagnostic Test: Polysomnography.
Sponsor:   Astes
Not yet recruiting

Study to Gain Insights in Treatment Patterns and Outcomes in Patients With Atherosclerosis Prescribed to Xarelto in Combination With Acetylsalicylic Acid

Condition:   Atherosclerosis
Interventions:   Drug: Rivaroxaban (BAY59-7939, Xarelto);   Drug: Acetylsalicylic acid
Sponsors:   Bayer;   Janssen, LP
Recruiting

An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Intervention:   Other: No treatment given
Sponsor:   Novo Nordisk A/S
Enrolling by invitation

Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >75 Years: the SCOPE-75 RCT Study

Condition:   Healthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular Disease
Interventions:   Drug: Low intensity statin;   Drug: Moderate intensity statin
Sponsor:   Yonsei University
Not yet recruiting

Calcium Administration in Cardiac Surgery

Conditions:   Cardiac Surgery;   Cardiopulmonary Bypass
Interventions:   Drug: Calcium Chloride;   Drug: 0.9% Sodium Chloride
Sponsors:   Meshalkin Research Institute of Pathology of Circulation;   Università Vita-Salute San Raffaele
Recruiting

Randomised Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients

Conditions:   Ischaemic Heart Disease;   Contrast-induced Nephropathy
Intervention:   Diagnostic Test: CTCA
Sponsor:   Queen Mary University of London
Recruiting

Early Initiation of Low Dose Tirofiban for Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

Condition:   ST Elevation Myocardial Infarction
Interventions:   Drug: Tirofiban;   Drug: Normal saline
Sponsor:   Shanghai Zhongshan Hospital
Not yet recruiting

Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue

Condition:   Myocardial Infarction
Interventions:   Combination Product: PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.;   Procedure: Surgery by sternotomy
Sponsors:   Fundació Institut Germans Trias i Pujol;   Germans Trias i Pujol Hospital
Not yet recruiting

Brazilian Cardioprotective Diet and Nuts in Post-acute Myocardial Infarction

Conditions:   Coronary Artery Disease;   Myocardial Infarction
Interventions:   Dietary Supplement: Brazilian cardioprotective diet;   Dietary Supplement: Brazilian cardioprotective diet plus 30g/day of nuts
Sponsor:   Hospital do Coracao
Recruiting

Modified T-Stenting With Szabo Technique Versus T-Stenting for Bifurcation Lesions in Coronary Heart Diseases

Condition:   Coronary Artery Disease
Interventions:   Procedure: Szabo T-Stenting Technique;   Procedure: T-Stenting Technique
Sponsor:   Shanghai Zhongshan Hospital
Recruiting

China Tongxinluo Study for Myocardial Protection in Patients With Acute Myocardial Infarction

Condition:   Acute Myocardial Infarction
Interventions:   Drug: Tongxinluo;   Drug: Placebos
Sponsor:   China National Center for Cardiovascular Diseases
Recruiting

Ross for Valve Replacement in AduLts Trial

Condition:   Aortic Valve Disease
Interventions:   Procedure: Ross procedure;   Procedure: Conventional aortic valve replacement
Sponsor:   Population Health Research Institute
Not yet recruiting

Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)

Conditions:   Stable Angina;   Acute Coronary Syndrome;   Coronary Stenosis
Intervention:   Genetic: CYP2C19 genotype testing
Sponsor:   Beijing Anzhen Hospital
Not yet recruiting

Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril in Patients With Arterial Hypertension and Stable CAD in Daily Clinical Practice

Conditions:   Arterial Hypertension;   CHD - Coronary Heart Disease
Intervention:   Drug: bisoprolol/perindopril FDC
Sponsor:   Servier Russia
Recruiting

EARLY MVO Assessing Using QFR After STEMI

Condition:   ST Segment Elevation Myocardial Infarction
Intervention:   Diagnostic Test: Computation of quantitative flow ratio
Sponsor:   RenJi Hospital
Completed

Multicentre REtrospective StuDy of Treatment and OUtComes in STEMI Patients in Fujian Province

Condition:   ST-segment Elevation Myocardial Infarction
Intervention:   Other: treatment and outcome
Sponsors:   Yan-song Guo;   Longyan City First Hospital;   The Affiliated Hospital of Putian University;   The Second Affiliated Hospital of Fujian Medical University;   The MinDong Hospital of Ningde City
Completed

Low Intensity Shockwaves Therapy for the Treatment of Erectile Dysfunction. 12- Month Follow-Up

Condition:   Erectile Dysfunction
Intervention:   Device: Shockwave therapy
Sponsor:   University of Miami
Not yet recruiting

Anti-platelet Precision Medicine to Prevent Stroke Early Progression and Recurrence (PRECISE)

Condition:   Stroke
Intervention:  
Sponsor:   Asan Medical Center
Recruiting

Reversing Diabetic Peripheral Neuropathy Through Exercise

Conditions:   Peripheral Neuropathy;   Diabetes
Intervention:  
Sponsor:   New York University School of Medicine
Recruiting

Ischemia Modified Albumin in Traumatic Brain Injury

Condition:   Traumatic Brain Injury
Intervention:   Diagnostic Test: Ischemia modified albumin (IMA)
Sponsor:   Kasr El Aini Hospital
Completed

BIOFLOW-SV Portugal Registry

Condition:   Ischemic Heart Disease
Intervention:   Device: Orsiro Sirolimus Eluting Coronary Stent System
Sponsor:   Biotronik AG
Recruiting

Pilot Study of Vitamin D Screening Use in Peripheral Arterial Disease Patient Over Maximum Distance Walking

Condition:   Peripheral Arterial Disease
Intervention:   Drug: Cholecalciferol
Sponsor:   University Hospital, Angers
Not yet recruiting

ACS Registry - A Non-interventional Study to Estimate the Rates of Outcomes in ACS Patients in Moscow

Conditions:   Heart Attack;   Stroke;   Cardiovascular Death
Intervention:  
Sponsor:   AstraZeneca
Recruiting

Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction

Conditions:   PreDiabetes;   Myocardial Infarction;   T2DM (Type 2 Diabetes Mellitus);   CVD
Intervention:   Drug: Dapagliflozin 10mg
Sponsor:   Hamad Medical Corporation
Not yet recruiting

Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized Cardiac Patients

Conditions:   OSA;   Heart Failure;   Myocardial Infarction;   Arrhythmia, Cardiac
Intervention:   Device: Continuous Positive Airway Pressure
Sponsor:   Kaiser Permanente
Not yet recruiting

The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy

Conditions:   Contrast-induced Nephropathy;   Acute Kidney Injury;   Acute Coronary Syndrome
Interventions:   Drug: Potassium Nitrate;   Drug: Potassium Chloride
Sponsor:   Barts & The London NHS Trust
Recruiting

FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease

Conditions:   Coronary Artery Disease;   NSTEMI - Non-ST Segment Elevation MI;   Fractional Flow Reserve, Myocardial;   Myocardial Revascularization;   Percutaneous Coronary Intervention
Interventions:   Procedure: Ischemia driven revascularization;   Other: Usual care group
Sponsors:   Zuyderland Medisch Centrum;   Maastricht University Medical Center;   Radboud University;   Jeroen Bosch Ziekenhuis;   VieCuri Medical Centre;   University Medical Center Groningen
Recruiting

Effect of Diabetes and Hepatic Enzymes Mutation on Clopidogrel VS Ticagrelor Activity in Myocardial Infarction (MI) Patients Undergoing Primary Percutaneous Coronary Intervention (PCI)

Condition:   Myocardial Infarction
Interventions:   Drug: Clopidogrel;   Drug: Ticagrelor 90mg
Sponsor:   Cairo University
Completed

Dabigatran Versus Warfarin With NVAF Who Undergo PCI

Conditions:   Atrial Fibrillation;   Coronary Artery Disease
Interventions:   Drug: dabigatran;   Drug: warfarin
Sponsors:   Shenyang Northern Hospital;   Beijing Anzhen Hospital;   Second Affiliated Hospital of Third Military Medical University
Recruiting

Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease

Conditions:   Patients Aged 65-85 (Both Included);   Diagnosed of Mild Cognitive Impairment;   Diagnosed of Type 2 Diabetes in Active Treatment (Hypoglycemic Agents) for a Period ≥5 Years
Interventions:   Device: Smart pillbox;   Other: Interactive digital platform
Sponsors:   Parc Sanitari Pere Virgili;   Hospital Universitari Vall d'Hebron (HUVH - VHIR);   Consorci Sanitari de Terrassa (CST);   Fundació Recerca Mútua Terrassa (FMT);   Clínica Universitària de la Fundació Universitària del Bages (FUB);   Althaia Xarxa Assistencial Universitària de Manresa;   Fundació Privada Hospital Asil de Granollers (HAG);   Consorci Hospitalari de Vic (CHV);   Lambdaloopers;   Universitat Politècnica de Catalunya (UPC);   Leitat;   Mixestat;   Meditecnologia;   Mind the Byte
Not yet recruiting

Study to Evaluate the QT / QTc Interval Prolongation Potential of Vericiguat

Condition:   Coronary Artery Disease
Interventions:   Drug: Vericiguat (BAY1021189);   Drug: Moxifloxacin;   Drug: Placebo
Sponsors:   Bayer;   Merck Sharp & Dohme Corp.
Active, not recruiting

Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study

Condition:   Coronary Artery Disease
Interventions:   Drug: Prasugrel;   Drug: Ticagrelor
Sponsors:   University of Florida;   Scott R MacKenzie Foundation
Recruiting

A Clinical Trial on No-touch Vein Graft (NT-graft) in Coronary Surgery

Condition:   Ischemic Heart Disease
Interventions:   Procedure: No touch technique;   Procedure: Control technique
Sponsor:   Uppsala University
Recruiting

VitalScan MCG Rule-out Multi-centre Pivotal Study - US

Condition:   Acute Coronary Syndrome
Intervention:   Device: VitalScan Magnetocardiograph
Sponsors:   University of Cincinnati;   Creavo Medical Technologies Ltd
Recruiting

Evaluation of Early CRRT and Beta-blocker InTerventions in Patients With ECMO(ELITE)

Condition:   Cardiogenic Shock
Interventions:   Device: Simultaneous CRRT;   Device: Conventional-indication CRRT;   Drug: Esmolol;   Drug: Standard care
Sponsors:   Beijing Anzhen Hospital;   The First Affiliated Hospital of Zhengzhou University
Recruiting

Platelet Reactivity And Clinical ThrombotIC Events Study

Conditions:   Acute Coronary Syndrome;   Antiplatelet Therapy;   Platelet Reactivity
Intervention:  
Sponsor:   Shenyang Northern Hospital
Recruiting

New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in ShangHai

Conditions:   Atrial Fibrillation;   Myocardial Infarction
Intervention:   Device: CEM
Sponsor:   Shanghai 10th People's Hospital
Recruiting

A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCI

Conditions:   Contrast-induced Acute Kidney Injury;   ST Elevation Myocardial Infarction;   Primary PCI;   Rosuvastatin;   Hydration
Interventions:   Drug: hydration plus rosuvastatin therapy;   Drug: Standard therapy
Sponsor:   Shenyang Northern Hospital
Not yet recruiting

Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus

Condition:   Microvascular Coronary Artery Disease
Interventions:   Drug: SAR247799;   Drug: Placebo;   Drug: Sildenafil;   Drug: Acetylcholine
Sponsor:   Sanofi
Completed

Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI

Conditions:   Diabetes Mellitus, Type 2;   Coronary Artery Disease
Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel
Sponsors:   University of Florida;   AstraZeneca
Recruiting

Hemodynamic Effects of Methylene Blue vs Hydroxocobalamin in Patients at Risk of Vasoplegia During Cardiac Surgery

Conditions:   Vasoplegia;   Hypotension;   Coronary Artery Disease;   Cardiac Valve Disease
Interventions:   Drug: Hydroxocobalamin;   Drug: Methylene Blue;   Drug: Normal saline
Sponsor:   Dartmouth-Hitchcock Medical Center
Not yet recruiting

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Condition:   Coronary Artery Disease
Interventions:   Drug: High dose potent statin;   Drug: ACE-I (lisinopril) or ARB (losartan);   Drug: Aspirin;   Behavioral: Lifestyle Counseling;   Behavioral: Quality of Life Questionnaires
Sponsors:   University of Florida;   United States Department of Defense
Recruiting

SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCI

Conditions:   Percutaneous Coronary Intervention;   Optical Coherence Tomography;   In-stent Coronary Artery Restenosis
Intervention:   Device: Optical Coherence Tomography
Sponsor:   Jesse Brown VA Medical Center
Recruiting

Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

Condition:   Acute Coronary Syndrome
Interventions:   Biological: Apolipoprotein A-I [human] (apoA-I);   Other: Placebo
Sponsor:   CSL Behring
Recruiting

Peripheral Nerve Blocks for Above-the-knee Amputations

Conditions:   Peripheral Vascular Diseases;   Hyperglycaemia (Diabetic);   Hypertension;   Coronary Artery Disease;   Pulmonary Disease, Chronic Obstructive
Interventions:   Procedure: Peripheral nerve block;   Drug: Intravenous Sedatives;   Procedure: Lateral femoral cutaneous nerve blocks;   Procedure: Obturator nerve blocks
Sponsors:   University of Florida;   US Department of Veterans Affairs
Recruiting

Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists

Condition:   Pulmonary Disease, Chronic Obstructive
Intervention:  
Sponsor:   Boehringer Ingelheim
Active, not recruiting

Absorb GT1 Japan PMS

Conditions:   Ischemic Heart Disease;   Angina Pectoris;   Coronary Artery Disease;   Coronary Artery Occlusion;   Myocardial Ischemia
Intervention:   Device: ABSORB GT1 BVS
Sponsor:   Abbott Medical Devices
Active, not recruiting

Low Dose Ticagrelor Versus Low Dose Prasugrel in Patients With Prior Myocardial Infarction

Conditions:   Myocardial Infarction;   Diabetes Mellitus;   Coronary Artery Disease;   Renal Disease
Interventions:   Drug: Ticagrelor 60 mg;   Drug: Prasugrel 5mg
Sponsor:   Attikon Hospital
Recruiting

An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD)

Condition:   Coronary Artery Disease (CAD)
Interventions:   Drug: PET MPI;   Drug: SPECT MPI;   Drug: Pharmacological stress agents
Sponsors:   GE Healthcare;   Pharmaceutical Product Development, LLC
Recruiting

The Greek AntiPlatElet Atrial Fibrillation Registry.

Conditions:   Atrial Fibrillation;   Coronary Artery Disease
Interventions:   Drug: VKA;   Drug: NOAC
Sponsors:   Attikon Hospital;   Hellenic Cardiological Society
Recruiting

Troponin Elevation After Major Noncardiac Surgery 2

Conditions:   Perioperative Myocardial Infarction;   Disability;   Perioperative/Postoperative Complications
Intervention:  
Sponsors:   UMC Utrecht;   University Health Network, Toronto
Recruiting

Correlation of Genetic Polymorphisms and Clinical Parameters With the Complexity of Coronary Artery Disease

Conditions:   Coronary Artery Disease;   Cardiovascular Risk Factor;   Coronary Arteriosclerosis
Intervention:   Genetic: SNPs associated with CAD
Sponsors:   Aristotle University Of Thessaloniki;   LABNET IAE - Private Reference Diagnostic Laboratory
Active, not recruiting

STEMI Cool Pilot Trial to Assess Cooling as an Adjunctive Therapy to PCI In Patients With Acute MI

Condition:   Acute Myocardial Infarction
Interventions:   Device: Cooling Procedure using the ZOLL Proteus IVTM System;   Device: PCI Only
Sponsor:   ZOLL Circulation, Inc., USA
Not yet recruiting

Integrated Coronary Imaging Registry

Condition:   Coronary Artery Disease
Interventions:   Other: OCT (Optical Coherence Tomography);   Other: selective CTA;   Other: FFR
Sponsor:   Yonsei University
Enrolling by invitation

Vascular Implant Safety and Efficacy Study

Condition:   Coronary Artery Disease
Intervention:   Device: Stent
Sponsors:   Biotronik CRC Inc.;   Biotronik AG
Recruiting

Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden

Condition:   Atrial Fibrillation
Intervention:   Drug: Antithrombotic agents
Sponsors:   Bayer;   Janssen Research & Development, LLC
Completed

Effect of Probiotic Supplementation on Endothelial Function II

Condition:   Cardiovascular Disease
Interventions:   Dietary Supplement: Goodbelly first;   Dietary Supplement: observation first
Sponsor:   Medical College of Wisconsin
Recruiting

A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI

Condition:   Microvascular Coronary Artery Disease
Interventions:   Drug: SAR407899;   Drug: Placebo;   Drug: Adenosine;   Drug: Regadenoson;   Drug: 13N-ammonia;   Drug: 82Rubidium
Sponsor:   Sanofi
Terminated

GLOBAL LEADERS Adjudication Sub-Study

Conditions:   Coronary Artery Disease;   Platelet-aggregation Inhibitors
Intervention:  
Sponsors:   University Hospital Inselspital, Berne;   European Cardiovascular Research Center
Active, not recruiting

Subclinical Cardiovascular Disease in Psoriatic Disease

Conditions:   Cardiovascular Diseases;   Myocardial Infarction;   Atherosclerotic Cardiovascular Disease;   Thrombotic Vascular Disease
Intervention:   Drug: Aspirin and/or Atorvastatin
Sponsor:   New York University School of Medicine
Recruiting

No-Touch Versus Conventional Saphenous Vein Harvesting Technique

Condition:   Coronary Artery Disease
Interventions:   Procedure: No-Touch vein harvesting technique;   Procedure: Conventional vein harvesting
Sponsor:   China National Center for Cardiovascular Diseases
Recruiting

ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest

Conditions:   Cardiac Arrest Due to Underlying Cardiac Condition;   Ventricular Fibrillation;   Cardiopulmonary Arrest With Successful Resuscitation
Interventions:   Procedure: Initial CCL admission;   Diagnostic Test: Initial ICU admission
Sponsor:   University of Minnesota - Clinical and Translational Science Institute
Recruiting

Catheter Ablation for Nonsustained Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy

Conditions:   Ventricular Tachycardia;   Ischemic Cardiomyopathy;   Reduced LVEF
Interventions:   Procedure: VT ablation;   Other: medication
Sponsor:   Heinrich-Heine University, Duesseldorf
Recruiting

Effects of the Insole on Balance Capacity in Chronic Stroke

Condition:   Stroke, Cardiovascular
Intervention:   Other: insole
Sponsor:   Taipei Medical University WanFang Hospital
Completed

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

Conditions:   Coronary Artery Disease;   Ischemic Heart Disease;   Non ST Segment Elevation Myocardial Infarction
Interventions:   Device: Orbital Atherectomy;   Device: Balloon
Sponsors:   Cardiovascular Systems Inc;   Cardiovascular Research Foundation, New York
Recruiting

Optimizing the Diagnosis of Heparin Induced Thrombocytopenia

Condition:   Heparin-induced Thrombocytopenia (HIT)
Intervention:   Diagnostic Test: Diagnostic algorithm
Sponsor:   Ottawa Hospital Research Institute
Recruiting

Coronary Anatomy Study and Times Since the Onset of Acute Myocardial Infarction Symptoms in Women Until the Opening of the Artery (TAPAC Study)

Condition:   Myocardial Infarction
Intervention:   Other: Non intervention
Sponsor:   Hospital Universitari Vall d'Hebron Research Institute
Recruiting

PCI Suite: Road Map Fusion Imaging in Coronary Diagnostics and Therapy

Condition:   Coronary Disease
Interventions:   Device: PCI Suite Software;   Other: conventional PCI
Sponsors:   Heinrich-Heine University, Duesseldorf;   Philips Medical Systems
Recruiting

RESOLUTE ONYX Post-Approval Study

Condition:   Coronary Artery Disease
Intervention:   Device: Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
Sponsor:   Medtronic Vascular
Recruiting

Determination of Coronarphysiological Parameters With the Method of Thermodillution

Condition:   Coronary Artery Stenosis of Unclear Hemodynamic Relevance
Intervention:  
Sponsor:   Heinrich-Heine University, Duesseldorf
Recruiting

RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases (RACING Trial)

Conditions:   Cardiovascular Diseases;   Cerebrovascular Disease;   Peripheral Atherosclerotic Disease
Interventions:   Drug: Rosuvastatin;   Drug: Rosuvastatin plus ezetimibe
Sponsor:   Yonsei University
Recruiting

Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)

Conditions:   Acute Renal Failure;   Kidney Diseases;   Chronic Kidney Disease;   Coronary (Artery); Disease
Intervention:  
Sponsors:   University of Pittsburgh;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   US Department of Veterans Affairs
Active, not recruiting

Mechanistic Effects of Colchicine in Patients With Myocardial Infarction

Condition:   Myocardial Infarction
Intervention:   Drug: Colchicine 0.6 mg tablets
Sponsor:   New York University School of Medicine
Completed

High-Sensitivity Cardiac Troponin T to OPtimize Chest Pain Risk Stratification

Conditions:   Acute Coronary Syndrome;   Chest Pain
Interventions:   Procedure: Blood Sample;   Behavioral: HEART Score
Sponsors:   University of Florida;   Roche Diagnostics
Active, not recruiting

Multi-modality Imaging in Acute Myocardial Infarction

Conditions:   Acute Myocardial Infarction;   STEMI;   Coronary Artery Disease;   Atherosclerotic Plaque Disruption With Thrombosis of Artery
Intervention:   Procedure: Coronary Angiography
Sponsor:   William Beaumont Hospitals
Recruiting

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

Conditions:   Prediabetic State;   Atherosclerosis;   Metformin
Interventions:   Drug: Metformin XR;   Drug: Placebo
Sponsor:   VA Office of Research and Development
Not yet recruiting

Clinical Significance of Pre-interventional Optical Coherence Tomography in Bioresorbable Vascular Scaffold Implantation

Condition:   Myocardial Ischemia
Interventions:   Device: Angiography-guided PCI with BVS;   Device: Optical coherence tomography-guided PCI with BVS
Sponsor:   Yonsei University
Terminated

Quantitative Cardiac Parametric Mapping (Myomapping)

Condition:   Cardiomyopathy, Myocarditis, Ischemic Heart Disease
Intervention:   Other: Cardiac Magnetic Resonance (CMR) imaging techniques
Sponsor:   Medical University of South Carolina
Recruiting

Acupuncture for Individuals With Stable Angina

Condition:   Angina, Stable
Interventions:   Other: Acupuncture;   Other: Non-pain related video health education
Sponsor:   University of Illinois at Chicago
Recruiting

Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention

Conditions:   Radial Artery Spasm;   Angina;   Coronary Artery Disease
Interventions:   Drug: Topical Nitroglycerine;   Drug: Topical Lidocaine
Sponsor:   Aultman Health Foundation
Recruiting

BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV

Condition:   Coronary Artery Disease
Intervention:   Device: Magmaris
Sponsor:   Biotronik AG
Recruiting

LEADERS FREE II: BioFreedom™ Pivotal Study

Conditions:   Acute Coronary Syndrome;   High Bleeding Risk
Interventions:   Device: BioFreedom™ Drug Coated Coronary Stent System;   Drug: Dual Antiplatelet Therapy
Sponsor:   Biosensors Europe SA
Active, not recruiting

Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up

Condition:   Coronary Artery Disease
Interventions:   Device: Coroflex® ISAR Drug-eluting stent;   Device: Ultimaster® Drug-eluting stent
Sponsors:   Hospital Universitari Vall d'Hebron Research Institute;   B.Braun Surgical SA
Completed

Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease

Condition:   Chronic Obstructive Pulmonary Disease (COPD)
Interventions:   Drug: Tetrahydrobiopterin (BH4);   Dietary Supplement: Antioxidant Cocktail
Sponsor:   Augusta University
Enrolling by invitation

Implementation of CYP2C19 Genotyping to Guide Antiplatelet Therapy

Condition:   Coronary Artery Disease
Intervention:   Device: SpartanRX
Sponsors:   University of Florida;   National Institutes of Health (NIH);   National Human Genome Research Institute (NHGRI)
Recruiting

Undiagnosed Sleep Apnea and Bypass OperaTion

Condition:   Sleep Apnea
Intervention:  
Sponsor:   National University, Singapore
Active, not recruiting

Conventional Versus Intentional StraTegy in Lesions With High Risk PrEdiction of Side Branch OccLusion in InterVEntion

Condition:   Coronary Artery Disease
Interventions:   Procedure: Conventional Strategy;   Procedure: Intentional strategy
Sponsor:   China National Center for Cardiovascular Diseases
Recruiting

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD

Conditions:   Diabetes Mellitus, Type 2;   Coronary Artery Disease;   Cardiovascular Diseases
Interventions:   Drug: RVX000222;   Drug: Placebo (for RVX000222);   Drug: atorvastatin;   Drug: rosuvastatin
Sponsors:   Resverlogix Corp;   PPD;   ICON plc;   Medidata Solutions
Active, not recruiting

Low-Density Lipoprotein Cholesterol-targeting Statin Therapy Versus the Intensity-based Statin Therapy in Patients With Coronary Artery Disease: a Randomized Comparison Trial

Condition:   Coronary Artery Diseasse
Interventions:   Drug: fixed high potent statin therapy;   Drug: targeted LDL-C goal statin
Sponsor:   Yonsei University
Recruiting

Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting

Condition:   Coronary Artery Disease, Hypercholesterolemia, Hypertension
Intervention:   Other: No intervention
Sponsor:   Pfizer
Completed

Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery Disease

Conditions:   Coronary Artery Disease;   Diabetes Mellitus
Intervention:   Drug: ticagrelor
Sponsor:   University of Florida
Recruiting

Cocoa Flavanol and Coronary Vasomotion Vascular Function in Patients With Coronary Artery Disease

Condition:   Stable Coronary Heart Disease
Intervention:   Dietary Supplement: flavanol-rich drink vs flavanol-free drink
Sponsor:   University of Zurich
Completed

How to Test Success of a Renal Denervation

Condition:   Hypertension, Resistant to Conventional Therapy
Intervention:  
Sponsor:   University of Zurich
Terminated

A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-eluting Stent Implantation

Condition:   Coronary Artery Disease
Interventions:   Device: BioFreedom with 1 month DAPT;   Device: BioMatrix Flex with 6 to 12 months DAPT
Sponsor:   Yonsei University
Recruiting

Reactivation of Varicella Zoster Virus and Risk of Vascular Disease

Conditions:   Varicella Zoster;   Stroke;   Transient Ischaemic Attack;   Acute Myocardial Infarction
Intervention:  
Sponsor:   University College, London
Withdrawn

Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor

Condition:   Myocardial Infarction
Interventions:   Drug: Prasugrel;   Drug: Vorapaxar;   Drug: Aspirin;   Drug: Ticagrelor
Sponsors:   University of Florida;   Merck Sharp & Dohme Corp.
Recruiting

Impact of Daylight on Patients With Acute Myocardial Infarction

Conditions:   Coronary Arteriosclerosis;   Myocardial Infarction
Interventions:   Other: Day Light;   Other: Room Light
Sponsor:   University of Colorado, Denver
Recruiting

Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device (SHIELD II)

Condition:   Coronary Artery Disease
Interventions:   Device: HeartMate PHP;   Device: Any Abiomed Impella® device approved for use in high-risk PCI
Sponsors:   St. Jude Medical;   Abbott
Recruiting

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities

Condition:   Peripheral Artery Disease
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Rivaroxaban-Placebo
Sponsors:   Bayer;   Janssen Research & Development, LLC;   Colorado Prevention Center
Active, not recruiting

Ugandan Non-Communicable Diseases and Aging Cohort

Conditions:   HIV;   Cardiovascular Disease;   Chronic Obstructive Pulmonary Disease;   Atherosclerosis;   Hypertension;   Diabetes Mellitus
Intervention:   Other: This is an observational study only
Sponsors:   Massachusetts General Hospital;   Mbarara University of Science and Technology;   University of California, San Francisco;   Ragon Institute of MGH, MIT and Harvard;   National Institutes of Health (NIH);   Harvard University
Completed

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Conditions:   Acute Coronary Syndrome;   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care drugs
Sponsors:   Bayer;   Janssen Scientific Affairs, LLC
Recruiting

The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome

Conditions:   Depression;   Acute Coronary Syndrome
Interventions:   Drug: Melatonin (N-acetyl-5-methoxytryptamine);   Drug: Placebo
Sponsors:   Zealand University Hospital;   Psychiatric Research Unit, Region Zealand, Denmark;   University of Copenhagen;   Pharma Nord
Completed

Study Comparing the MiStent SES Versus the XIENCE EES Stent

Condition:   Coronary Stenosis
Interventions:   Device: MiStent;   Device: XIENCE EES
Sponsors:   ECRI bv;   Micell Technologies;   Stentys
Active, not recruiting

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Condition:   Acute Coronary Syndromes
Interventions:   Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
Sponsors:   Bristol-Myers Squibb;   Pfizer;   Duke Clinical Research Institute
Completed

The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery

Conditions:   Coronary Artery Disease;   Stable Angina;   Acute Coronary Syndrome
Interventions:   Drug: Ticagrelor;   Drug: Placebo
Sponsors:   J.M. ten Berg;   AstraZeneca
Active, not recruiting

Trial of a Novel Paclitaxel-coated Balloon With Citrate Excipient for Restenosis in -Limus Analogue DES

Condition:   Coronary Restenosis
Intervention:   Device: PCB
Sponsor:   Deutsches Herzzentrum Muenchen
Completed

Prospective International Study of Coronary Subtraction Using 320 Detector Row CT (CorSub)

Condition:   Coronary Artery Disease
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly

Conditions:   Non-ST-elevation Acute Coronary Syndrome;   Unstable Angina;   Non-ST-elevation Myocardial Infarction
Interventions:   Drug: Clopidogrel;   Drug: Ticagrelor or Prasugrel
Sponsors:   St. Antonius Hospital;   UMC Utrecht;   Leiden University Medical Center;   Meander Medical Center;   Medical Center Alkmaar;   Isala;   Gelre Hospitals;   Gelderse Vallei Hospital;   Medical Centre Leeuwarden;   Rijnstate Hospital
Active, not recruiting

Remote Ischemic Conditioning in ST-elevation Myocardial Infarction as Adjuvant to Primary Angioplasty

Condition:   ST Elevation Myocardial Infarction
Intervention:   Other: Remote ischaemic conditioning
Sponsors:   Hospital de Braga;   Universidade do Porto
Completed

Polymorphisms in CD36 and STAT3 Genes and Different Dietary Interventions Among Patients With Coronary Artery Disease

Condition:   Coronary Artery Disease
Interventions:   Dietary Supplement: Olive oil;   Dietary Supplement: Nuts;   Dietary Supplement: Control diet
Sponsors:   Instituto de Cardiologia do Rio Grande do Sul;   Conselho Nacional de Desenvolvimento Científico e Tecnológico;   Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
Active, not recruiting

Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome

Conditions:   Stable Angina;   Metabolic Syndrome
Interventions:   Drug: Ranolazine;   Drug: Placebo
Sponsor:   University of Florida
Active, not recruiting

Usefulness of Coronary Computed Tomography Angiography for Therapeutic Decision- Making; Revascularization

Condition:   Coronary Artery Disease, Ischemic Heart Disease
Intervention:  
Sponsor:   Yonsei University
Recruiting

CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function

Condition:   ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
Intervention:   Drug: CD-NP
Sponsor:   Mayo Clinic
Completed

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsors:   Bayer;   Janssen Research & Development, LLC
Active, not recruiting

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsors:   Bayer;   Janssen Scientific Affairs, LLC
Recruiting

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin;   Drug: Antiplatelet drugs
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting

Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial

Conditions:   Coronary Artery Disease;   Myocardial Infarction
Interventions:   Device: ABSORB BVS™;   Device: XIENCE™
Sponsor:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Active, not recruiting

Proton Radiation for Stage II/III Breast Cancer

Conditions:   Breast Cancer;   Breast Neoplasm;   Breast Tumor;   Cancer of the Breast
Intervention:   Radiation: Proton Radiotherapy
Sponsor:   Proton Collaborative Group
Active, not recruiting

Myocardial Perfusion and Scarring in Congenital Heart Disease

Condition:   Congenital Heart Disease
Intervention:  
Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   Children's Research Institute;   Suburban Hospital
Suspended

Evaluating New Radiation Techniques for Cardiovascular Imaging

Condition:   Coronary Disease
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

Condition:   Coronary Artery Disease
Interventions:   Drug: Prasugrel Loading Dose;   Drug: Prasugrel Maintenance Dose;   Drug: Ticagrelor Maintenance Dose
Sponsors:   Daiichi Sankyo, Inc.;   Eli Lilly and Company
Completed

Prevention of Serious Adverse Events Following Angiography

Conditions:   Acute Renal Failure;   Kidney Disease;   Coronary Artery Disease
Interventions:   Drug: IV isotonic saline;   Drug: IV isotonic bicarbonate;   Drug: N-acetylcysteine;   Drug: Placebo
Sponsors:   VA Office of Research and Development;   The George Institute
Completed

COroNary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter Registry (CONFIRM)

Conditions:   Atherosclerosis;   Coronary Artery Disease;   Cardiovascular Disease
Intervention:  
Sponsor:   Weill Medical College of Cornell University
Enrolling by invitation

Vest Prevention of Early Sudden Death Trial and VEST Registry

Conditions:   Myocardial Infarction;   Ventricular Dysfunction;   Sudden Death;   Ventricular Tachycardia;   Ventricular Fibrillation
Intervention:   Device: wearable defibrillator
Sponsors:   University of California, San Francisco;   Zoll Medical Corporation
Active, not recruiting

Evaluation of Effectiveness and Safety of BIOMATRIX Stent (IRIS-BIOMATRIX)

Condition:   Coronary Artery Disease
Intervention:  
Sponsors:   Seung-Jung Park;   CardioVascular Research Foundation, Korea;   Dio
Active, not recruiting

The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease

Condition:   Coronary Artery Disease
Interventions:   Drug: Prasugrel;   Drug: Clopidogrel
Sponsor:   Daiichi Sankyo, Inc.
Completed

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

Conditions:   Coronary Artery Disease;   Percutaneous Transluminal Coronary Angioplasty
Intervention:  
Sponsors:   Seung-Jung Park;   CardioVascular Research Foundation, Korea
Recruiting

A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis

Condition:   Relapsing Multiple Sclerosis
Intervention:   Drug: Laquinimod
Sponsor:   Teva Pharmaceutical Industries, Ltd.
Terminated

Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients

Conditions:   Unstable Angina;   Non ST Segment Elevation Myocardial Infarction (NSTEMI);   Stable Angina (Associated With High Risk PCI)
Interventions:   Drug: ALX-0081;   Drug: ReoPro®
Sponsor:   Ablynx
Completed

A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course

Condition:   Relapsing Multiple Sclerosis
Intervention:   Drug: Laquinimod
Sponsor:   Teva Pharmaceutical Industries, Ltd.
Terminated

Comparison of Cardiac Computed Tomography and Vasodilator Stress Magnetic Resonance Imaging Perfusion in Patients With Prior Equivocal Stress Test for Detection of Coronary Artery Disease

Conditions:   Myocardial Ischemia;   Coronary Artery Disease;   Myocardial Infarction
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Suspended

Insulin Resistance and Atherosclerosis in Women With Lupus

Conditions:   Systemic Lupus Erythematosus;   Insulin Resistance;   Atherosclerosis
Intervention:  
Sponsor:   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Completed

ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study

Conditions:   Healthy Volunteers;   Atherosclerotic Heart Disease
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting

Genetic Factors in Atherosclerosis

Condition:   Atherosclerosis
Intervention:  
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed

A Genome-Wide Scan For Quantitative Trait Loci of Serum Bilirubin - A Framingham Study

Condition:   Genetics
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed

Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)

Conditions:   Atherosclerosis;   Cardiovascular Disease;   Vascular Diseases
Intervention:  
Sponsor:   National Institute on Aging (NIA)
Terminated

Technical Development of Cardiovascular Magnetic Resonance Imaging

Conditions:   Cardiomyopathy;   Congenital Heart Disease;   Cardiovascular Disease;   Cardiac Magnetic Resonance Imaging;   Acute Myocardial Infarction
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Suspended